Bitcoin Hold $65,000 After Bounce Sparks Crypto Hope
Bitcoin stabilized near $65,000 after a two-day slide, supported by renewed ETF inflows and a shift in options positi...
Which Credit Card Has No Annual Fee
Searching for a credit card with no annual fee? Explore our top picks to save money and maximize your benefits without extra costs.
27,821 articles
Plaintiff Says I Wanted Time: Social Media Trial Unfolds
A young plaintiff testifies in a civil trial accusing major platforms of harming mental health, focusing on a compuls...
CCJ’s Long Term Contract Strategy: Strength and Ceiling
Cameco beat revenue and earnings targets, driven by ccj’s long term contract book that locks in cash flow through 202...
Top Performing Defensive Stocks in Volatile Markets
As markets swing in early 2026, performing defensive stocks have provided steadier returns, drawing cash into staples...
Tariff Refund Delays Could Cost U.S. $700M Monthly
Tariff refund delays could threaten cash flow for thousands of importers, with a Cato Institute estimate placing the ...
This Million Sale Slashed DigitalBridge Stake Amid 49% Surge
A large fund trimmed its DigitalBridge position, sparking questions about stake moves, stock momentum, and how invest...
Utah Named Dave Refused: A 4-H Finance Lesson for Families
When a Utah boy kept his 4-H pig Dave, the internet cheered and learned a money lesson at the same time. This is more...
KVHI 2025 Earnings Call Preview: What Investors Need to Know
As KVHI gears up for the 2025 earnings call, investors should focus on revenue drivers, margins, and long-term strate...
Vera Bradley (VRA) 2026 Outlook: Q4 Earnings and Revenue
Investors are eyeing Vera Bradley's 2026 path as it rhythms through product launches, wholesale relationships, and di...
SpaceX IPO: Reason This Is the Top Space Stock to Watch in 2026
As SpaceX eyes a public debut, one argument stands above the rest for why it could become the premier space stock in ...
Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Benchmark Cuts Price Target for Bakkt by Nearly 50%
Benchmark lowered its Bakkt price target by about 47%, arguing that near-term monetization remains elusive as the com...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status